65,437 trials
Cystic Fibrosis (CF)
Primary: Change in Sweat Chloride Concentration in Millimoles/Liter From Baseline at 6 Months Pre-specified to be Reported — 10.2 mmol/L
Late Preterm Infant
Primary: Phone Call Completion Rate — 194; 102; 59; 52 calls
Malignant Pleural Mesothelioma · Non-Small Cell Lung Cancer
Primary: Phase 1 Part: Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Adverse Drug Reactions (ADRs) — 4; 0; 0; 1 Participants
Obesity · Diabetes · Covid19
Primary: Number of Participants Who Used the Intensive Behavioral Therapy (IBT) Service — 2417; 3731 Participants
Unresectable Adenocarcinoma of the Esophagus · Metastatic Adenocarcinoma of the Esophagus · Unresectable Adenocarcinoma of Gastric Cardia
Primary: Overall Response Rate of Previously-untreated Patients With Unresectable or Metastatic Adenocarcinomas of the Upper Gastrointestinal Tract When Treated With the…
Covid19
Primary: The Incidence of COVID-2019 Cases. — 259.95 COVID-2019 cases per 1000 person
CKD Anemia
Primary: United States (US FDA) Submission: Mean Change From Baseline in Hb (g/dL) Over Weeks 28 to 52 Regardless of Rescue Therapy — 9.10; 9.09; 2.00; 0.16 g/dL — p=<0.0001
Stress Disorders, Post-Traumatic
Primary: Mean (SD) Change in Post-Traumatic Stress Disorder Checklist - Military Version (PCL-M) Scores From Baseline to End of Double-Blind Phase — 65.78; 65.25; -22.45; -14.75…
Patients Undergoing Photodynamic Therapy Using Porfimer Sodium
Primary: The First Day on Which Patients Are Free From Symptoms of Phototoxicity Following Phototesting
Chronic Kidney Disease · End Stage Renal Disease · Anemia
Primary: Change From Baseline in Hb Over Time — 10.05; 1.26; 1.58; 1.94 g/dL
Diabetes
Primary: Humalog Subjects - Rate of Infusion Set Failure at the End of Day 6 — 0.06 Percentage of Extended Wear Infusion Set
Intracerebral Hemorrhage · Stroke, Acute · Stroke Hemorrhagic
Primary: Number of Patients With Serious Device-related Adverse Events — 0 Participants
Dialysis · Anemia
Primary: Maximum Change From Baseline in Hb During Weeks 3-13 — 8.1; 8.5; 8.4; 8.7 grams/deciliter (g/dL) — p=0.0757
Anemia in Incident Dialysis Patients
Primary: US (FDA) Submission: Mean Hb Change From Baseline to The Average Level During The Evaluation Period (Week 28 to Week 52), Regardless of Rescue Therapy (ITT Population)…
Diabetes Mellitus · Type 1 Diabetes
Primary: Number of All Consented Participants — 12; 12 Participants